Soft-tissue sarcomas are tumors that can happen in many different tissues in the body. Most soft-tissue sarcomas begin in the arms, legs, or the body wall. People usually first notice a painless lump, ...

Soft tissue sarcomas are cancers that develop in your body’s soft tissues like muscle, fat, tendons, or cartilage. Your legs are the most common place they develop. The American Cancer Society ...

Sarcomas are complex cancers that can affect patients of all ages. A number of sarcoma diagnoses may respond to initial treatment, but may recur (come back) or turn into advanced disease over time. In ...

Radiotherapy was associated with an 8.1-fold increased risk of developing a thoracic soft tissue sarcoma in one cohort (95% CI 1.1-60.4, P=0.0052) and 3.0-fold elevated risk in the other (95% CI 2.4-3 ...

University of Maryland School of Medicine researchers are investigating a new approach to treat high-risk soft-tissue sarcomas by combining two immunotherapy drugs with radiation therapy to stimulate ...

Positive data from Stage 1 of the Phase IIa clinical trial (QB46C-H07) evaluating QBiotics' small molecule, tigilanol tiglate in 11 (10 evaluable) patients with advanced Soft Tissue Sarcoma (STS). An ...

2021 JUL 05 (NewsRx) -- By a News Reporter-Staff News Editor at Health Policy and Law Daily-- A new study on Oncology - Soft Tissue Sarcomas is now available. According to news reporting out of ...

Early palliative care, intensity of end-of-life care, and their impact on overall survival in cancer patients: A real-world study. Post-propensity score matching univariate analysis for palliative ...

Pregnancy Outcome of Partners of Male Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study Methods: Clinicopathologic features and immunohistochemical expression of Skp2, ...

Mec-V demonstrates median OS of 21.5 months in patients with treatment-refractory leiomyosarcoma, liposarcoma, and undifferentiated pleomorphic sarcoma compared with approximately 12 months with ...

SOTIO Biotech, a clinical-stage biopharmaceutical company owned by PPF Group, today announced favorable preclinical results ...